|
|
|
Volumn 58, Issue 10, 2000, Pages 2066-2071
|
|
The new Parkinson's disease drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARKINSON AGENT;
BROMOCRIPTINE;
CATECHOL METHYLTRANSFERASE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENZYME INHIBITOR;
LEVODOPA;
MONOAMINE OXIDASE INHIBITOR;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG COMBINATION;
HUMAN;
PARKINSON DISEASE;
REVIEW;
ANTIPARKINSON AGENTS;
BROMOCRIPTINE;
CATECHOL O-METHYLTRANSFERASE;
CLINICAL TRIALS;
DOPAMINE AGONISTS;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HUMANS;
LEVODOPA;
MONOAMINE OXIDASE INHIBITORS;
PARKINSON DISEASE;
|
|
EID: 0034293393
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (13)
|
